AGEX THERAPEUTICS INC stock forecast: up to 0.78 USD AGE stock price prognosis

STOCK

Forecast for Fri 17 Nov 2023 price 0.81

AGEX THERAPEUTICS INC stock price forecast for further price development up to 36.71% (time horizon: 1 day) and price target of 0.78 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) AGEX THERAPEUTICS INC share price prediction for 2023-11-17 with daily closed price projections

Key Facts

Symbol AGE 

ISIN US00848H1086 

CUSIP 00848H108

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.60)

News <--> Close correlation for next day influence (-0.12)

Finance numbers

Revenue 1,835,000.0

Earnings per share -0.27

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

These patents are the foundation for our Univercyte™ technology platform. & However, each alternative has potential disadvantages as well. Therefore, it is possible to generate clonal lineages of these cells in vitro. Flow cytometry shows purity indistinguishable from 100%. & Our inventions relating to iTR biologics disclose both DNA and RNA-based strategies. As a result, we have not yet assembled an infrastructure for sales and marketing. The expiration dates of the HyStem® patents range from 2023 to 2027. & The requirements governing drug pricing vary widely from country to country. Two full-time and one part-time employees hold Ph. 9679;Third-party manufacturers could breach or terminate their agreements with us. & &# 9679;We will face similar regulatory issues in foreign countries. & The use of hES cells may give rise to religious, moral, and ethical issues. In addition, there is a natural transition period when a new third party commences work. We do not have current plans to pay any cash dividends on our common stock. There is no guarantee that securities analysts will cover our common stock. See Note 4 to our consolidated financial statements included elsewhere in this Report. &

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1708599/000149315221007461/0001493152-21-007461.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 17.36/100
    • Good financial position.
    • Company revenue is not growing faster compared with the industry.

Institutional ownership list is based on filling form information

Holding name Date Amount
Pacifica Partners Inc. 2023-06-30 292
Strategic Wealth Investment Group, LLC 2023-03-31 86026
JPMORGAN CHASE & CO 2023-03-31 14
VANGUARD GROUP INC 2023-03-31 698414
CWM, LLC 2023-03-31 214

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2023-02-28 60587 Long
Fidelity Concord Street Trust 2023-05-31 24431 Long
Fidelity Concord Street Trust 2023-05-31 10213 Long
Fidelity Concord Street Trust 2023-05-31 59696 Long
Bridgeway Funds, Inc. 2023-06-30 140000 Long
Assets / Liabilities

Bollinger Bollinger Bands for AGEX THERAPEUTICS INC can provide the information where the market is moving based on price information.

AGEX THERAPEUTICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns AGEX THERAPEUTICS INC.

On-Balance Volume information for AGEX THERAPEUTICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for AGEX THERAPEUTICS INC. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for AGEX THERAPEUTICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for AGEX THERAPEUTICS INC. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for AGEX THERAPEUTICS INC. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for AGEX THERAPEUTICS INC. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for AGEX THERAPEUTICS INC. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

Heikin Ashi trading signals are generated based on the Heikin Ashi candles, which are a type of candlestick that smooths out the price action and can help to identify trends. Heikin Ashi signals can be used to identify both long and short trading opportunities.

The awesome oscillator is a momentum indicator that measures the speed and strength of price movements. It is calculated by subtracting a 34-period simple moving average (SMA) from a 5-period SMA.

The Parabolic SAR indicator is a trend-following indicator that uses a series of dots to indicate when a trend is likely to reverse. The Parabolic SAR is a lagging indicator, meaning that it does not predict reversals, but rather confirms them after they have already occurred.

52W High 52W Low Market Cap

Similar shares

Trend:
chart
IBIO INC

Trend:
chart
Oncorus, Inc

Trend:
chart
INFINITY PHARMACEUTICALS INC

News sentiment

Trend:
chart
APTEVO THERAPEUTICS INC

News sentiment

AGEX THERAPEUTICS INC on Nasdaq

AGEX THERAPEUTICS INC on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-10-19 0.78 2023-09-23 15:34
2023-09-25 0.75 2023-09-23 15:34
2023-09-26 0.76 2023-09-23 15:34
2023-10-20 0.79 2023-09-23 15:34
2023-10-06 0.77 2023-09-23 15:34
2023-10-13 0.78 2023-09-23 15:34
2023-09-29 0.75 2023-09-23 15:34
2023-10-05 0.78 2023-09-23 15:34
2023-09-28 0.75 2023-09-23 15:34
2023-10-02 0.76 2023-09-23 15:34
2023-10-03 0.77 2023-09-23 15:34
2023-11-02 0.80 2023-09-23 15:34
2023-10-09 0.77 2023-09-23 15:34
2023-10-10 0.78 2023-09-23 15:34
2023-10-16 0.78 2023-09-23 15:34
2023-11-08 0.80 2023-09-23 15:34
2023-10-04 0.77 2023-09-23 15:34
2023-11-13 0.81 2023-09-23 15:34
2023-11-14 0.81 2023-09-23 15:34
2023-10-18 0.78 2023-09-23 15:34
2023-11-03 0.80 2023-09-23 15:34
2023-10-27 0.79 2023-09-23 15:34
2023-11-10 0.81 2023-09-23 15:34
2023-10-11 0.78 2023-09-23 15:34
2023-10-12 0.78 2023-09-23 15:34
2023-10-23 0.79 2023-09-23 15:34
2023-10-24 0.79 2023-09-23 15:34
2023-10-17 0.78 2023-09-23 15:34
2023-11-15 0.81 2023-09-23 15:34
2023-09-27 0.76 2023-09-23 15:34
2023-10-25 0.79 2023-09-23 15:34
2023-11-09 0.80 2023-09-23 15:34
2023-11-06 0.80 2023-09-23 15:34
2023-11-07 0.80 2023-09-23 15:34
2023-11-16 0.81 2023-09-23 15:34
2023-10-30 0.79 2023-09-23 15:34
2023-10-31 0.80 2023-09-23 15:34
2023-11-01 0.80 2023-09-23 15:34
2023-10-26 0.79 2023-09-23 15:34
2023-11-17 0.81 2023-09-23 15:34

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.